Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder

Condition:   Opioid-use Disorder Interventions:   Drug: Buprenorphine/naloxone;   Drug: Placebo Sponsors:   New York State Psychiatric Institute;   National Institute on Drug Abuse (NIDA) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials